This invention relates to the extraction of psychoactive compounds from organisms for use in medicine. Extraction is carried out with a strong acid or strong base to either promote or inhibit dephosphorylation. The extract in the slurry form is standardized with added excipient so that when it is dried the powdered composition has a specified total psychoactive alkaloid concentration, with a known ratio of phosphorylated to dephosphorylated psychoactive alkaloids.

The present invention provides a high-content carotenoid compound from Adonis amurensis. The content of the total carotenoid of the carotenoid compound is higher than 95%. The content of all-trans (3S, 3′S)-carotenoid is higher than 80%. The carotenoid crystals have a high purity, and can be used in multiple forms in the fields of a dietary supplement of a human being, a food additive, a feed additive and a cosmetic product. In addition, the present invention also provides a method for manufacturing the compound.

A system and method for creating a botanical extract. The system comprising a grow light optimized to stimulate growth of the selected plant and an extractor using supercritical CO.sub.2 to obtain the extract.

Described herein are pharmaceutical compositions comprising cannabinoids. In some embodiments, such compositions are useful for the treatment of inflammatory, autoimmune diseases or disorders, cancer, or neurodegenerative diseases. Further provided herein are pharmaceutical compositions comprising combinations of cannabinoids possessing entourage effects.

The present invention relates to a novel natural extraction method for cannabinoid without using any additives, alcohol, or butane. The method is configured to extract sap from the cannabis via high-pressure, heated water rather than butane or alcohol. More specifically, natural ingredients such as calcium, magnesium, organic citrus, and mint are used and mixed together with cannabis strain in a coffee filter or cheese cloth filter for heating in water. The water, having the ingredients positioned and packaged similar to a tea bag therein, is either boiled for two hours in a crockpot or for seven minutes in a pressure cooker for providing sap and bud of cannabis. In some embodiments, the cannabis strain is dried and grinded before mixing with other ingredients. The method offers a way to extract cannabinoids swiftly and easily for making cannabis edibles.

The present disclosure provides a food for hangover and liver protection and a producing method thereof. The method includes: providing the raw materials of particular percentages by weight, wherein the prepared turmeric powder accounts for 25%-35% of the provided raw materials; the prepared kudzu isoflavone powder accounts for 30%-40% of the provided raw materials; the prepared Primula sieboldii root powder accounts for 20%-30% of the provided raw materials; the prepared fruit extract accounts for 5%-14% of the provided raw materials; and the prepared vitamin complex accounts for 1%-2% of the provided raw materials; performing a sieving pretreatment on each of the provided raw materials; putting the pretreated raw materials into a wet granulator to perform a mix process for obtaining the food; and performing a testing process on the mixed food, and re-performing the mix process on the tested food in response to the tested food being unqualified.

An antidepressant food and a method for preparing the same are provided. The antidepressant food includes, by mass percentage, Semen ziziphi spinosae powder in a range of 28% to 36%, γ-aminobutyric acid in a range of 10% to 15%, theanine in a range of 15% to 20%, phosphatidylserine in a range of 10% to 20%, Ficus tikoua extract in a range of 8% to 14%, Huperzia serrata extract in a range of 10% to 16%, sucralose in a range of 0.5% to 1% and fruit essence in a range of 0.5% to 1.5%.

Proposed is an anti-obesity functional feed composition for companion animals, the composition including Geumhwagyu (Hibiscus manihot L.) extract as an active ingredient. The Geumhwagyu (Hibiscus manihot L.) extract induces the degradation of CEBPα (CCAAT/enhancer-binding protein-α), thereby inhibiting the differentiation of preadipocytes. In addition, the Geumhwagyu (Hibiscus manihot L.) extract inhibits the expression of peroxisome proliferator-activated receptor-γ (PPARγ), CCAAT/enhancer-binding protein-α (CEBPα), perilipin-1, adiponectin, fatty acid binding protein-4 (FABP4), etc., thereby inhibiting the accumulation of lipids in adipocytes. Thus, the Geumhwagyu (Hibiscus manihot L.) extract shows anti-obesity activity by lowering the content of triacylglycerol (TG).

The present invention “use of Maitake and Maitake polysaccharide D Fraction in manufacture of medicaments for anti-depression” belongs to the field of pharmaceuticals, which characterized in that the Maitake whole herb, Maitake extract or Maitake polysaccharide D fraction is used in the preparation of antidepressants. The medicament can be used to treat or prevent depression, which has a significant antidepressant effect, not only strong effect, but also no conventional antidepressant medicaments toxicity, side effects, such as induced epilepsy, ataxia and other shortcomings. Therefore, they can be used as an excellent antidepressant candidate medicament.

An aspect of the present invention provides a pharmaceutical composition containing Camellia japonica extract derived from a natural substance as an active ingredient for prevention and treatment of viral infection, wherein the extract inhibits viral replication and release from cells to effectively regulate viral infection, thus exhibiting an excellent antiviral effect.